Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,448,817
-
Share change
-
+1,405,837
-
Total reported value
-
$1,784,968,110
-
Put/Call ratio
-
65%
-
Price per share
-
$36.10
-
Number of holders
-
156
-
Value change
-
-$13,294,176
-
Number of buys
-
80
-
Number of sells
-
87
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2018
As of 31 Dec 2018,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,448,817 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Foresite Capital Management III, LLC, Partner Fund Management, L.P., Foresite Capital Management II, LLC, CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Bank of New York Mellon Corp.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.